Клобромазолам

Clobromazolam is a synthetic benzodiazepine derivative. It is structurally related to other triazolobenzodiazepines and is believed to act as a potent sedative and hypnotic through positive allosteric modulation of the GABAA receptor. The compound was first described in the early 1980s during research into novel anxiolytic and hypnotic agents, but it was never developed or approved for medical use. Clobromazolam has emerged in the 21st century as a designer drug, being sold online and detected in forensic casework. It was first identified in seized samples by a Swedish laboratory in March 2016. Due to its high potency and lack of clinical evaluation, its use has been associated with significant safety concerns, including the risk of overdose, dependence, and severe central nervous system depression.

Also known as: Fenozalam

Classification

Chemical: Benzodiazepine
Psychoactive: Depressant

Effects

Sedation
Motor Impairment
Reduced Anxiety
Amnesia
Dulled Perception

Routes of Administration

No route information available yet.

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

wikipedia.org

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu